Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease
ItalyStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
ItalyStudy Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated
ItalyStudy of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment
ItalyStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
ItalyStudy on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease
ItalyStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
ItalyStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
ItalyStudy of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses
ItalyStudy on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy
ItalyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
ItalyStudy on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
